Fetal anomalies and long-term effects associated with substance abuse in pregnancy: A literature review

American Journal of Perinatology

Volumn 32, Issue 5, 2015, Pages 405-416

  Viteri, Oscar A ^a   Soto, Eleazar E ^a   Bahado Singh, Ray O ^b   Christensen, Carl W ^c   Chauhan, Suneet P ^a   Sibai, Baha M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

amphetamines; cocaine; marijuana; methadone; opioids; pregnancy

Indexed keywords

ALCOHOL; AMPHETAMINE; AMPHETAMINE DERIVATIVE; CANNABIS; COCAINE; OPIATE;

CENTRAL NERVOUS SYSTEM MALFORMATION; CHILD BEHAVIOR; CHILD GROWTH; COGNITION; DISEASE ASSOCIATION; FACE DYSMORPHIA; FEMALE; FETUS; FETUS MALFORMATION; HIGH RISK BEHAVIOR; HUMAN; LANGUAGE; LONG TERM EXPOSURE; META ANALYSIS (TOPIC); NONHUMAN; PREGNANCY; PRENATAL CARE; PRENATAL EXPOSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SMOKING; SUBSTANCE ABUSE; SYSTEMATIC REVIEW (TOPIC); ADDICTION; ADVERSE EFFECTS; COMPLICATION; CONGENITAL MALFORMATION; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY;

FEMALE; FETUS; HUMANS; MATERNAL EXPOSURE; PREGNANCY; PRENATAL CARE; PRENATAL EXPOSURE DELAYED EFFECTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SUBSTANCE-RELATED DISORDERS;

EID: 84927611718     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0034-1393932     Document Type: Review

References (128)

1. Substance Abuse and Mental Health Services Administration Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. Rockville, MD Substance Abuse and Mental Health Services Administration: 2013
2. Terplan M., Smith E. J., Kozloski M. J., Pollack H. A. Methamphetamine use among pregnant women. Obstet Gynecol: 2009; 113 6 1285 1291
3. Creanga A. A., Sabel J. C., Ko J. Y., et al. Maternal drug use and its effect on neonates: a population-based study in Washington State. Obstet Gynecol: 2012; 119 5 924 933
4. Schenker S., Yang Y., Johnson R. F., et al. The transfer of cocaine and its metabolites across the term human placenta. Clin Pharmacol Ther: 1993; 53 3 329 339
5. Ganapathy V. Drugs of abuse and human placenta. Life Sci: 2011; 88 21-22 926 930
6. Hoyme H. E., Jones K. L., Dixon S. D., et al. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics: 1990; 85 5 743 747
7. van den Anker J. N., Cohen-Overbeek T. E., Wladimiroff J. W., Sauer P. J. Prenatal diagnosis of limb-reduction defects due to maternal cocaine use. Lancet: 1991; 338 8778 1332
8. Webster W. S., Brown-Woodman P. D. Cocaine as a cause of congenital malformations of vascular origin: experimental evidence in the rat. Teratology: 1990; 41 6 689 697
9. Bingol N., Fuchs M., Diaz V., Stone R. K., Gromisch D. S. Teratogenicity of cocaine in humans. J Pediatr: 1987; 110 1 93 96
10. Lutiger B., Graham K., Einarson T. R., Koren G. Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis. Teratology: 1991; 44 4 405 414
11. Addis A., Moretti M. E., Ahmed Syed F., Einarson T. R., Koren G. Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol: 2001; 15 4 341 369
12. van Gelder M. MHJ, Reefhuis J., Caton A. R., Werler M. M., Druschel C. M., Roeleveld N.; National Birth Defects Prevention Study. Maternal periconceptional illicit drug use and the risk of congenital malformations. Epidemiology: 2009; 20 1 60 66
13. Lipshultz S. E., Frassica J. J., Orav E. J. Cardiovascular abnormalities in infants prenatally exposed to cocaine. J Pediatr: 1991; 118 1 44 51
14. Singer L. T., Arendt R., Minnes S., et al. Cognitive and motor outcomes of cocaine-exposed infants. JAMA: 2002; 287 15 1952 1960
15. Harvey J. A. Cocaine effects on the developing brain: current status. Neurosci Biobehav Rev: 2004; 27 8 751 764
16. Hurt H., Brodsky N. L., Betancourt L., Braitman L. E., Malmud E., Giannetta J. Cocaine-exposed children: follow-up through 30 months. J Dev Behav Pediatr: 1995; 16 1 29 35
17. Covington C. Y., Nordstrom-Klee B., Ager J., Sokol R., Delaney-Black V. Birth to age 7 growth of children prenatally exposed to drugs: a prospective cohort study. Neurotoxicol Teratol: 2002; 24 4 489 496
18. Jacobson J. L., Jacobson S. W., Sokol R. J. Effects of prenatal exposure to alcohol, smoking, and illicit drugs on postpartum somatic growth. Alcohol Clin Exp Res: 1994; 18 2 317 323
19. Miller J. M. Jr, Boudreaux M. C., Regan F. A. A case-control study of cocaine use in pregnancy. Am J Obstet Gynecol: 1995; 172 1 Pt 1 180 185
20. Richardson G. A., Conroy M. L., Day N. L. Prenatal cocaine exposure: effects on the development of school-age children. Neurotoxicol Teratol: 1996; 18 6 627 634
21. Warner T. D., Behnke M., Hou W., Garvan C. W., Wobie K., Eyler F. D. Predicting caregiver-reported behavior problems in cocaine-exposed children at 3 years. J Dev Behav Pediatr: 2006; 27 2 83 92
22. Accornero V. H., Anthony J. C., Morrow C. E., Xue L., Bandstra E. S. Prenatal cocaine exposure: an examination of childhood externalizing and internalizing behavior problems at age 7 years. Epidemiol Psichiatr Soc: 2006; 15 1 20 29
23. Linares T. J., Singer L. T., Kirchner H. L., et al. Mental health outcomes of cocaine-exposed children at 6 years of age. J Pediatr Psychol: 2006; 31 1 85 97
24. Sood B. G., Nordstrom Bailey B., Covington C., et al. Gender and alcohol moderate caregiver reported child behavior after prenatal cocaine. Neurotoxicol Teratol: 2005; 27 2 191 201
25. Bendersky M., Bennett D., Lewis M. Aggression at age 5 as a function of prenatal exposure to cocaine, gender, and environmental risk. J Pediatr Psychol: 2006; 31 1 71 84
26. Dennis T., Bendersky M., Ramsay D., Lewis M. Reactivity and regulation in children prenatally exposed to cocaine. Dev Psychol: 2006; 42 4 688 697
27. Arendt R. E., Short E. J., Singer L. T., et al. Children prenatally exposed to cocaine: developmental outcomes and environmental risks at seven years of age. J Dev Behav Pediatr: 2004; 25 2 83 90
28. Leech S. L., Richardson G. A., Goldschmidt L., Day N. L. Prenatal substance exposure: effects on attention and impulsivity of 6-year-olds. Neurotoxicol Teratol: 1999; 21 2 109 118
29. Bandstra E. S., Morrow C. E., Anthony J. C., Accornero V. H., Fried P. A. Longitudinal investigation of task persistence and sustained attention in children with prenatal cocaine exposure. Neurotoxicol Teratol: 2001; 23 6 545 559
30. Savage J., Brodsky N. L., Malmud E., Giannetta J. M., Hurt H. Attentional functioning and impulse control in cocaine-exposed and control children at age ten years. J Dev Behav Pediatr: 2005; 26 1 42 47
31. Mayes L., Snyder P. J., Langlois E., Hunter N. Visuospatial working memory in school-aged children exposed in utero to cocaine. Child Neuropsychol: 2007; 13 3 205 218
32. Ebrahim S. H., Gfroerer J. Pregnancy-related substance use in the United States during 1996-1998. Obstet Gynecol: 2003; 101 2 374 379
33. Bell G. L., Lau K. Perinatal and neonatal issues of substance abuse. Pediatr Clin North Am: 1995; 42 2 261 281
34. Musshoff F., Madea B. Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. Ther Drug Monit: 2006; 28 2 155 163
35. Khare M., Taylor A. H., Konje J. C., Bell S. C. Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription. Mol Hum Reprod: 2006; 12 5 321 333
36. Witter F. R., Niebyl J. R. Marijuana use in pregnancy and pregnancy outcome. Am J Perinatol: 1990; 7 1 36 38
37. Gibson G. T., Baghurst P. A., Colley D. P. Maternal alcohol, tobacco and cannabis consumption and the outcome of pregnancy. Aust N Z J Obstet Gynaecol: 1983; 23 1 15 19
38. Shaw G. M., Velie E. M., Morland K. B. Parental recreational drug use and risk for neural tube defects. Am J Epidemiol: 1996; 144 12 1155 1160
39. Hingson R., Alpert J. J., Day N., et al. Effects of maternal drinking and marijuana use on fetal growth and development. Pediatrics: 1982; 70 4 539 546
40. Williams L. J., Correa A., Rasmussen S. Maternal lifestyle factors and risk for ventricular septal defects. Birth Defects Res A Clin Mol Teratol: 2004; 70 2 59 64
41. Torfs C. P., Velie E. M., Oechsli F. W., Bateson T. F., Curry C. J. A population-based study of gastroschisis: demographic, pregnancy, and lifestyle risk factors. Teratology: 1994; 50 1 44 53
42. Goldschmidt L., Day N. L., Richardson G. A. Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol: 2000; 22 3 325 336
43. Fried P. A. Adolescents prenatally exposed to marijuana: examination of facets of complex behaviors and comparisons with the influence of in utero cigarettes. J Clin Pharmacol: 2002; 42 11 97S 102S
44. Fried P. A., Watkinson B., Gray R. Differential effects on cognitive functioning in 13- to 16-year-olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol: 2003; 25 4 427 436
45. Fried P. A., Watkinson B., Gray R. Differential effects on cognitive functioning in 9- to 12-year olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol: 1998; 20 3 293 306
46. Fried P. A., Smith A. M. A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotoxicol Teratol: 2001; 23 1 1 11
47. Fried P. A., Watkinson B. Differential effects on facets of attention in adolescents prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol: 2001; 23 5 421 430
48. Goldschmidt L., Richardson G. A., Cornelius M. D., Day N. L. Prenatal marijuana and alcohol exposure and academic achievement at age 10. Neurotoxicol Teratol: 2004; 26 4 521 532
49. Porath A. J., Fried P. A. Effects of prenatal cigarette and marijuana exposure on drug use among offspring. Neurotoxicol Teratol: 2005; 27 2 267 277
50. Kellogg A., Rose C. H., Harms R. H., Watson W. J. Current trends in narcotic use in pregnancy and neonatal outcomes. Am J Obstet Gynecol: 2011; 204 3 e1 e4
51. Azadi A., Dildy G. A. III. Universal screening for substance abuse at the time of parturition. Am J Obstet Gynecol: 2008; 198 5 e30 e32
52. Broussard C. S., Rasmussen S. A., Reefhuis J., et al. National Birth Defects Prevention Study. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol: 2011; 204 4 e1 e11
53. Markham J. K., Emmerson J. L., Owen N. V. Teratogenicity studies of methadone HCl in rats and rabbits. Nature: 1971; 233 5318 342 343
54. Jones H. E., Kaltenbach K., Heil S. H., et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med: 2010; 363 24 2320 2331
55. Cleary B. J., Donnelly J. M., Strawbridge J. D., et al. Methadone and perinatal outcomes: a retrospective cohort study. Am J Obstet Gynecol: 2011; 204 2 e1 e9
56. Arlettaz R., Kashiwagi M., Das-Kundu S., Fauchère J-C, Lang A., Bucher H-U. Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Acta Obstet Gynecol Scand: 2005; 84 2 145 150
57. Schindler S. D., Eder H., Ortner R., Rohrmeister K., Langer M., Fischer G. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction: 2003; 98 1 103 110
58. Welle-Strand G. K., Skurtveit S., Jones H. E., et al. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009. Drug Alcohol Depend: 2013; 127 1-3 200 206
59. Zierler S., Rothman K. J. Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. N Engl J Med: 1985; 313 6 347 352
60. Bracken M. B. Drug use in pregnancy and congenital heart disease in offspring. N Engl J Med: 1986; 314 17 1120
61. Rothman K. J., Fyler D. C., Goldblatt A., Kreidberg M. B. Exogenous hormones and other drug exposures of children with congenital heart disease. Am J Epidemiol: 1979; 109 4 433 439
62. Thomas D. B. Cleft palate, mortality and morbidity in infants of substance abusing mothers. J Paediatr Child Health: 1995; 31 5 457 460
63. Saxén I. Associations between oral clefts and drugs taken during pregnancy. Int J Epidemiol: 1975; 4 1 37 44
64. Behnke M., Smith V. C.; Committee on Substance Abuse; Committee on Fetus and Newborn. Prenatal substance abuse: short- and long-term effects on the exposed fetus. Pediatrics: 2013; 131 3 e1009 e1024
65. Shankaran S., Lester B. M., Das A., et al. Impact of maternal substance use during pregnancy on childhood outcome. Semin Fetal Neonatal Med: 2007; 12 2 143 150
66. Hamilton R., McGlone L., MacKinnon J. R., Russell H. C., Bradnam M. S., Mactier H. Ophthalmic, clinical and visual electrophysiological findings in children born to mothers prescribed substitute methadone in pregnancy. Br J Ophthalmol: 2010; 94 6 696 700
67. Rosen T. S., Johnson H. L. Long-term effects of prenatal methadone maintenance. NIDA Res Monogr: 1985; 59 73 83
68. Lifschltz M. H., Wilson G. S. Patterns of growth and development in narcotic-exposed children. NIDA Res Monogr: 1991; 114 323 339
69. Derauf C., LaGasse L. L., Smith L. M., et al. Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant development, environment, and lifestyle study (IDEAL). Am J Drug Alcohol Abuse: 2007; 33 2 281 289
70. Little B. B., Snell L. M., Gilstrap L. C. III. Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet Gynecol: 1988; 72 4 541 544
71. Oei J. L., Kingsbury A., Dhawan A., et al. Amphetamines, the pregnant woman and her children: a review. J Perinatol: 2012; 32 10 737 747
72. McElhatton P. R., Bateman D. N., Evans C., Pughe K. R., Thomas S. H. Congenital anomalies after prenatal ecstasy exposure. Lancet: 1999; 354 9188 1441 1442
73. Singer L. T., Moore D. G., Min M. O., et al. One-year outcomes of prenatal exposure to MDMA and other recreational drugs. Pediatrics: 2012; 130 3 407 413
74. Singer L. T., Moore D. G., Fulton S., et al. Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy. Neurotoxicol Teratol: 2012; 34 3 303 310
75. Milkovich L., van der Berg B. J. Effects of antenatal exposure to anorectic drugs. Am J Obstet Gynecol: 1977; 129 6 637 642
76. Draper E. S., Rankin J., Tonks A. M., et al. Recreational drug use: a major risk factor for gastroschisis? Am J Epidemiol: 2008; 167 4 485 491
77. Chang L., Smith L. M., LoPresti C., et al. Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res: 2004; 132 2 95 106
78. Eriksson M., Jonsson B., Steneroth G., Zetterström R. Cross-sectional growth of children whose mothers abused amphetamines during pregnancy. Acta Paediatr: 1994; 83 6 612 617
79. Cernerud L., Eriksson M., Jonsson B., Steneroth G., Zetterström R. Amphetamine addiction during pregnancy: 14-year follow-up of growth and school performance. Acta Paediatr: 1996; 85 2 204 208
80. Sokol R. J., Delaney-Black V., Nordstrom B. Fetal alcohol spectrum disorder. JAMA: 2003; 290 22 2996 2999
81. Bosco C., Diaz E. Placental hypoxia and foetal development versus alcohol exposure in pregnancy. Alcohol Alcohol: 2012; 47 2 109 117
82. Hankin J. R., Sokol R. J. Identification and care of problems associated with alcohol ingestion in pregnancy. Semin Perinatol: 1995; 19 4 286 292
83. Jones K. L., Smith D. W., Ulleland C. N., Streissguth P. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet: 1973; 1 7815 1267 1271
84. de Sanctis L., Memo L., Pichini S., Tarani L., Vagnarelli F. Fetal alcohol syndrome: new perspectives for an ancient and underestimated problem. J Matern Fetal Neonatal Med: 2011; 24 01 34 37
85. Polygenis D., Wharton S., Malmberg C., et al. Moderate alcohol consumption during pregnancy and the incidence of fetal malformations: a meta-analysis. Neurotoxicol Teratol: 1998; 20 1 61 67
86. Henderson J., Gray R., Brocklehurst P. Systematic review of effects of low-moderate prenatal alcohol exposure on pregnancy outcome. BJOG: 2007; 114 3 243 252
87. Clarren S. K., Alvord E. C. Jr, Sumi S. M., Streissguth A. P., Smith D. W. Brain malformations related to prenatal exposure to ethanol. J Pediatr: 1978; 92 1 64 67
88. Martínez-Frías M. L., Bermejo E., Rodríguez-Pinilla E., Frías J. L. Risk for congenital anomalies associated with different sporadic and daily doses of alcohol consumption during pregnancy: a case-control study. Birth Defects Res A Clin Mol Teratol: 2004; 70 4 194 200
89. Strömland K. Visual impairment and ocular abnormalities in children with fetal alcohol syndrome. Addict Biol: 2004; 9 2 153 157, discussion 159-160
90. Feldman H. S., Jones K. L., Lindsay S., et al. Prenatal alcohol exposure patterns and alcohol-related birth defects and growth deficiencies: a prospective study. Alcohol Clin Exp Res: 2012; 36 4 670 676
91. DeRoo L. A., Wilcox A. J., Drevon C. A., Lie R. T. First-trimester maternal alcohol consumption and the risk of infant oral clefts in Norway: a population-based case-control study. Am J Epidemiol: 2008; 168 6 638 646
92. Mateja W. A., Nelson D. B., Kroelinger C. D., Ruzek S., Segal J. The association between maternal alcohol use and smoking in early pregnancy and congenital cardiac defects. J Womens Health (Larchmt): 2012; 21 1 26 34
93. Davies J. K., Bledsoe J. M. Prenatal alcohol and drug exposures in adoption. Pediatr Clin North Am: 2005; 52 5 1369 1393, vii
94. Streissguth A. P., Sampson P. D., Olson H. C., et al. Maternal drinking during pregnancy: attention and short-term memory in 14-year-old offspring-a longitudinal prospective study. Alcohol Clin Exp Res: 1994; 18 1 202 218
95. Coles C. D., Platzman K. A., Raskind-Hood C. L., Brown R. T., Falek A., Smith I. E. A comparison of children affected by prenatal alcohol exposure and attention deficit, hyperactivity disorder. Alcohol Clin Exp Res: 1997; 21 1 150 161
96. Streissguth A. P., Bookstein F. L., Barr H. M., Sampson P. D., O'Malley K., Young J. K. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. J Dev Behav Pediatr: 2004; 25 4 228 238
97. Nanson J. L., Hiscock M. Attention deficits in children exposed to alcohol prenatally. Alcohol Clin Exp Res: 1990; 14 5 656 661
98. Howell K. K., Lynch M. E., Platzman K. A., Smith G. H., Coles C. D. Prenatal alcohol exposure and ability, academic achievement, and school functioning in adolescence: a longitudinal follow-up. J Pediatr Psychol: 2006; 31 1 116 126
99. Kodituwakku P. W., Kalberg W., May P. A. The effects of prenatal alcohol exposure on executive functioning. Alcohol Res Health: 2001; 25 3 192 198
100. Streissguth A. P., Barr H. M., Sampson P. D. Moderate prenatal alcohol exposure: effects on child IQ and learning problems at age 7 1/2 years. Alcohol Clin Exp Res: 1990; 14 5 662 669
101. Coles C. D., Brown R. T., Smith I. E., Platzman K. A., Erickson S., Falek A. Effects of prenatal alcohol exposure at school age. I. Physical and cognitive development. Neurotoxicol Teratol: 1991; 13 4 357 367
102. Goldschmidt L., Richardson G. A., Stoffer D. S., Geva D., Day N. L. Prenatal alcohol exposure and academic achievement at age six: a nonlinear fit. Alcohol Clin Exp Res: 1996; 20 4 763 770
103. Olson H. C., Streissguth A. P., Sampson P. D., Barr H. M., Bookstein F. L., Thiede K. Association of prenatal alcohol exposure with behavioral and learning problems in early adolescence. J Am Acad Child Adolesc Psychiatry: 1997; 36 9 1187 1194
104. Zdravkovic T., Genbacev O., McMaster M. T., Fisher S. J. The adverse effects of maternal smoking on the human placenta: a review. Placenta: 2005; 26 (Suppl A): S81 S86
105. Little J., Cardy A., Munger R. G. Tobacco smoking and oral clefts: a meta-analysis. Bull World Health Organ: 2004; 82 3 213 218
106. Wyszynski D. F., Duffy D. L., Beaty T. H. Maternal cigarette smoking and oral clefts: a meta-analysis. Cleft Palate Craniofac J: 1997; 34 3 206 210
107. Hackshaw A., Rodeck C., Boniface S. Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. Hum Reprod Update: 2011; 17 5 589 604
108. Feltes B. C., de Faria Poloni J., Notari D. L., Bonatto D. Toxicological effects of the different substances in tobacco smoke on human embryonic development by a systems chemo-biology approach. PLoS ONE: 2013; 8 4 e61743
109. Salmasi G., Grady R., Jones J., McDonald S. D.; Knowledge Synthesis Group. Environmental tobacco smoke exposure and perinatal outcomes: a systematic review and meta-analyses. Acta Obstet Gynecol Scand: 2010; 89 4 423 441
110. Milne E., Greenop K. R., Scott R. J., et al. Parental smoking and risk of childhood brain tumors. Int J Cancer: 2013; 133 1 253 259
111. Fried P. A., James D. S., Watkinson B. Growth and pubertal milestones during adolescence in offspring prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol: 2001; 23 5 431 436
112. Kristjansson E. A., Fried P. A., Watkinson B. Maternal smoking during pregnancy affects children's vigilance performance. Drug Alcohol Depend: 1989; 24 1 11 19
113. Fried P. A., Watkinson B., Gray R. A follow-up study of attentional behavior in 6-year-old children exposed prenatally to marihuana, cigarettes, and alcohol. Neurotoxicol Teratol: 1992; 14 5 299 311
114. Thapar A., Fowler T., Rice F., et al. Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. Am J Psychiatry: 2003; 160 11 1985 1989
115. Kotimaa A. J., Moilanen I., Taanila A., et al. Maternal smoking and hyperactivity in 8-year-old children. J Am Acad Child Adolesc Psychiatry: 2003; 42 7 826 833
116. Brook J. S., Brook D. W., Whiteman M. The influence of maternal smoking during pregnancy on the toddler's negativity. Arch Pediatr Adolesc Med: 2000; 154 4 381 385
117. Day N. L., Richardson G. A., Goldschmidt L., Cornelius M. D. Effects of prenatal tobacco exposure on preschoolers' behavior. J Dev Behav Pediatr: 2000; 21 3 180 188
118. Wakschlag L. S., Hans S. L. Maternal smoking during pregnancy and conduct problems in high-risk youth: a developmental framework. Dev Psychopathol: 2002; 14 2 351 369
119. Batstra L., Hadders-Algra M., Neeleman J. Effect of antenatal exposure to maternal smoking on behavioural problems and academic achievement in childhood: prospective evidence from a Dutch birth cohort. Early Hum Dev: 2003; 75 1-2 21 33
120. Naeye R. L. Cognitive and behavioral abnormalities in children whose mothers smoked cigarettes during pregnancy. J Dev Behav Pediatr: 1992; 13 6 425 428
121. Fergusson D. M., Horwood L. J., Lynskey M. T. Maternal smoking before and after pregnancy: effects on behavioral outcomes in middle childhood. Pediatrics: 1993; 92 6 815 822
122. Fergusson D. M., Woodward L. J., Horwood L. J. Maternal smoking during pregnancy and psychiatric adjustment in late adolescence. Arch Gen Psychiatry: 1998; 55 8 721 727
123. Williams G. M., O'Callaghan M., Najman J. M., et al. Maternal cigarette smoking and child psychiatric morbidity: a longitudinal study. Pediatrics: 1998; 102 1 e11
124. Räsänen P., Hakko H., Isohanni M., Hodgins S., Järvelin M. R., Tiihonen J. Maternal smoking during pregnancy and risk of criminal behavior among adult male offspring in the Northern Finland 1966 Birth Cohort. Am J Psychiatry: 1999; 156 6 857 862
125. Weissman M. M., Warner V., Wickramaratne P. J., Kandel D. B. Maternal smoking during pregnancy and psychopathology in offspring followed to adulthood. J Am Acad Child Adolesc Psychiatry: 1999; 38 7 892 899
126. Fried P. A., O'Connell C. M., Watkinson B. 60- and 72-month follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol: cognitive and language assessment. J Dev Behav Pediatr: 1992; 13 6 383 391
127. Cornelius M. D., Ryan C. M., Day N. L., Goldschmidt L., Willford J. A. Prenatal tobacco effects on neuropsychological outcomes among preadolescents. J Dev Behav Pediatr: 2001; 22 4 217 225
128. Fried P. A., Watkinson B., Siegel L. S. Reading and language in 9- to 12-year olds prenatally exposed to cigarettes and marijuana. Neurotoxicol Teratol: 1997; 19 3 171 183